PHYTRICARE
LIVE

Serial Number

79366121

Owner

EVONIK OPERATIONS GMBH

Attorney

Scott D. Woldow

Filing Date

Nov 29, 2022

Add to watchlist:

No watchlists yet
View on USPTO

PHYTRICARE Trademark

Serial Number: 79366121 • Registration: 7445250

PHYTRICARE is a trademark filed by EVONIK OPERATIONS GMBH on November 29, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 31 (Natural Agricultural Products). The application is currently registered and active.

Owner Contact Info

EVONIK OPERATIONS GMBH (461 trademarks)

RELLINGHAUSER STRASSE 1-11
ESSEN 45128 , DE

Entity Type: 16

Trademark Details

Filing Date

November 29, 2022

Registration Date

July 16, 2024

Published for Opposition

April 30, 2024

Goods & Services

Pharmaceutical preparations for treating inflammation conditions and metabolic conditions; pharmaceutical preparations for nutrition, namely, nutritional supplements; veterinary preparations for treating inflammation conditions and metabolic conditions; veterinary preparations for nutrition, namely, nutritional supplements for veterinary purposes; medical preparations for the treatment of inflammation conditions and metabolic conditions; medical preparations for nutrition chemical preparations for nutrition, namely, nutritional supplements for medical purposes; medicated additives for animal foods, namely, animal feed additives for use as nutritional supplements for medical purposes; additives with medicinal effects for feed, namely, animal feed additives for use as nutritional supplements for medical purposes; chemical preparations for inflammation conditions and metabolic conditions for medical, pharmaceutical and veterinary purposes; chemical preparations for nutrition, namely, nutritional supplements for medical, pharmaceutical and veterinary purposes; medicated animal feed; medicated supplements for animal feedstuffs; amino acids for medical and veterinary purposes; cellulose esters for pharmaceutical purposes, medicinal oils and greases for medical and veterinary purposes; salt products, namely, potassium iodide and sodium salts for medical purposes; steroids; biological preparations for the treatment of metabolic disorders for medical and veterinary purposes; ferments for pharmaceutical purposes; yeast dietary supplements; yeast for pharmaceutical purposes; starch for pharmaceutical purposes; enzymes and enzyme preparations, all for medical and veterinary purposes; bacterial preparations for medical and veterinary purposes; bacteriological preparations for medical and veterinary purposes; cultures of microorganisms for medical and veterinary use; nutritive substances for microorganisms for medical purposes; bouillons for bacteriological cultures for medical or veterinary purposes; probiotic supplements; probiotic bacterial preparations for veterinary use; probiotic preparations for medical use featuring bacterial formulations; probiotic supplements for dietetic use; food supplements in the nature of antioxidants; sanitary preparations for medical purposes; dietetic foods adapted for medical and veterinary use; dietetic preparations adapted for medical purposes; dietetic animal foodstuffs for medical purposes; nutritional supplements; albuminous dietetic preparations adapted for medical purposes; medicated confectionery; medicinal drinks; dietetic beverages adapted for medical purposes; dietetic preparations adapted for medical use; medical preparations for slimming purposes; nutritional supplements for humans; dietary supplements for animals; dietetic preparations adapted for medical purposes and for use as dietary supplements; sugar in the nature of candy and glucose for medical purposes; glucose for medical purposes; dietetic albuminous animal foodstuffs for medical purposes; protein dietary supplements; dietary fibre to aid digestion; mineral food supplements; nutritional preparations, namely, nutritional supplements containing trace elements for human and animal use; vitamin preparations; feed supplements in the nature of amino acids for veterinary purposes, synthetic peptides for the treatment of inflammation, metabolic conditions, nutrition deficiency, and protein supplements for use in animal feed, fish food and aquacultures; animal feed supplements, not for medical purposes; nutritional supplements, namely, flavonoids for use as a dietary supplement

Products for aquaculture, namely, aquaculture feed; live animals; foodstuffs and fodder for animals; preparations for use as animal feed; foodstuffs for fish; aquaculture feed; foodstuffs for animals containing botanical extracts; yeast for animal consumption

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 17, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 27, 2024 FICS
FINAL DISPOSITION PROCESSED
Dec 27, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 17, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 16, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 16, 2024 R.PR
REGISTERED-PRINCIPAL REGISTER
Jul 16, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Apr 30, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 30, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 30, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 10, 2024 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 10, 2024 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 10, 2024 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 25, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 25, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 25, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 25, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 25, 2024 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Mar 18, 2024 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 18, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 18, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 18, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 18, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 18, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 18, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 18, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 18, 2024 TROA
REFUSAL PROCESSED BY IB
Aug 29, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 4, 2023 RFCS
REFUSAL PROCESSED BY MPU
Aug 4, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 28, 2023 RFCR
NON-FINAL ACTION WRITTEN
Jun 27, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 19, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 4, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 31, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 30, 2023 REPR